Cure51 has announced the UK launch of the Rosalind study, a groundbreaking initiative already underway in other parts of Europe that aims to unlock the secrets of exceptional cancer survivors.
Read more
NHS study to unlock cancer survival secrets
Rosalind Study
The science
Publication Date:
TO READ NEXT
Table of Contents
MORE ARTICLES IN THIS TOPIC
RELATED ARTICLES
MORE TOP STORIES
Cure51 and Servier sign a long-term Target ID partnership on Glioblastoma in a deal up to €442M per target to discover novel therapies.
Building a Product Ecosystem for Cancer Target Discovery
CHUV Lausanne received their Rosalind trophy!
Our CEO Nicolas Wolikow: "Turning precision medicine into an operational reality"
How Cure51 Builds a Global Cancer Research Project Across 50+ Countries
